Complement activation in the aqueous humor of pseudophakic bullous keratopathy patients

Ophthalmic Research

Volumn 49, Issue 3, 2013, Pages 161-166

  Füst, Ágnes ^a   Csuka, Dorottya ^b   Süveges, Ildikó ^a   Imre, László ^a   Bausz, Mária ^a   Nagymihály, Attila ^a   Csorvási, Ágnes ^a   Füst, György ^b   Németh, János ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Aqueous humor; Complement activation; Corneal endothelium; Pseudophakic bullous keratopathy

Indexed keywords

BRINZOLAMIDE; COMPLEMENT COMPONENT C3A; COMPLEMENT FACTOR; DEXAMETHASONE; DORZOLAMIDE PLUS TIMOLOL; FLUOROMETHOLONE; ZYMOSAN;

AGED; AQUEOUS HUMOR; ARTICLE; CATARACT EXTRACTION; CLINICAL ARTICLE; COLOBOMA; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CORNEA ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE SURGERY; FEMALE; HUMAN; IN VITRO STUDY; KERATOPATHY; KERATOPLASTY; MALE; PHACOEMULSIFICATION; PRIORITY JOURNAL;

EID: 84871227855     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000345066     Document Type: Article

References (21)

1. Cameron MD, Poyer JF, Aust SD: Identification of free radicals produced during phacoemulsification. J Cataract Refract Surg 2001; 27: 463-670.
2. Cheng H, Jacobs PM, McPherson K, Noble MJ: Precision of cell density estimates and endothelial cell loss with age. Arch Ophthalmol 1985; 103: 1478-1481.
3. Bourne RR, Minassian DC, Dart JK, Rosen P, Kaushal S, Wingate N: Effect of cataract surgery on the corneal endothelium: modern phacoemulsification compared with extracapsular cataract surgery. Ophthalmology 2004; 111: 679-685.
4. Rosenbaum JT, Planck ST, Huang XN, Rich L, Ansel JC: Detection of mRNA for the cytokines, interleukin-1 alpha and interleukin-8, in corneas from patients with pseudophakic bullous keratopathy. Invest Ophthalmol Vis Sci 1995; 36: 2151-2155.
5. Dernouchamps JP, Vaerman JP, Michiels J, Masson PL: Immune complexes in the aqueous humor and serum. Am J Ophthalmol 1977; 84: 24-31.
6. Tuberville AW, Wood TO: Aqueous humor protein and complement in pseudophakic eyes. Cornea 1990; 9: 249-253.
7. Jurkunas UV, Bitar MS, Rawe I, Harris DL, Colby K, Joyce NC: Increased clusterin expression in Fuchs' endothelial dystrophy. Invest Ophthalmol Vis Sci 2008; 49: 2946-2955.
8. Kerenyi A, Nagy G, Veres A, Varga L, Fust A, Nagymihaly A, Czumbel N, Suveges I, Fust G: C1r-C1s-C1inhibitor (C1rs-C1inh) complex measurements in tears of patients before and after penetrating keratoplasty. Curr Eye Res 2002; 24: 99-104.
9. Botto M, Kirschfink M, Macor P, Pickering MC, Würzner R, Tedesco F: Complement in human diseases: lessons from complement deficiencies. Mol Immunol 2009; 46: 2774-2783.
10. Rao GN, Aquavella JV, Goldberg SH, Berk SL: Pseudophakic bullous keratopathy. Relationship to preoperative corneal endothelial status. Ophthalmology 1984; 91: 1135-1140.
11. Geffen N, Topaz M, Kredy-Farhan L, Barequet IS, Farzam N, Assia EI, Savion N: Phacoemulsification-induced injury in corneal endothelial cells mediated by apoptosis: in vitro model. J Cataract Refract Surg 2008; 34: 2146-2152.
12. Lai LJ, Chen YF, Wu S, Tsao YP, Tsai RJ: Endothelial cell loss induced by phacoemulsification occurs through apoptosis. Chang Gung Med J 2001; 24: 621-627.
13. Li QJ, Ashraf MF, Shen D, Green WR, Stark WJ, Chan C, O'Brien TP: The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. Arch Ophthalmol 2001; 119: 1597-1604.
14. Trouwa LA, Blomb AM, Gasque P: Role of complement and complement regulators in the removal of apoptotic cells. Review. Mol Immunol 2008; 45: 1199-1207.
15. Tuberville AW, Poston WM, Wood TO: Aqueous humor cytology of pseudophakic bullous keratopathy. J Am Intraocul Implant Soc 1984; 10: 329-332.
16. van Gelderen BE, Van der Lelij A, Peek R, Broersma L, Treffers WF, Ruijter JM, van der Gaag R: Cytokines in aqueous humour and serum before and after corneal transplantation and during rejection. Ophthalmic Res 2000; 32: 157-164.
17. Sohn JH, Kaplan HJ, Suk HJ, Puran S, Bora PS, Bora NS: Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59. Invest Ophthalmol Vis Sci 2000; 41: 4195-4202.
18. Sohn JH, Kaplan HJ, Suk HJ, Bora PS, Bora NS: Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Invest Ophthalmol Vis Sci 2000; 41: 3492-3502.
19. Hargrave SL, Mayhew E, Hegde S, Niederkorn J: Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection? Transpl Immunol 2003; 11: 79-89.
20. Bora NS, Gobleman CL, Atkinson JP, Pepose JS, Kaplan HJ: Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci 1993; 34: 3579-3584.
21. Emlen W, Li W, Kirschfink M: Therapeutic complement inhibition: new developments. Semin Thromb Hemost 2010; 36: 660-668.